Published in Int J Geriatr Psychiatry on December 01, 2009
Sleep quality and 1-year incident cognitive impairment in community-dwelling older adults. Sleep (2012) 1.27
Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry (2011) 1.14
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment. Psychol Med (2012) 0.90
Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Am J Geriatr Psychiatry (2014) 0.81
The Alzheimer's disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline. Dement Geriatr Cogn Dis Extra (2014) 0.80
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease. Am J Neurodegener Dis (2016) 0.76
Validity of the Korean version of the fear of Alzheimer's disease scale for the assessment of anticipatory dementia. J Korean Med Sci (2014) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
A rating scale for depression. J Neurol Neurosurg Psychiatry (1960) 90.89
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry (2001) 3.07
Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry (1996) 2.99
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr (2004) 2.54
Mild cognitive impairment: directions for future research. Neurology (2003) 1.78
Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry (1998) 1.76
The Spielberger State-Trait Anxiety Inventory (STAI): the state scale in detecting mental disorders in geriatric patients. Int J Geriatr Psychiatry (2005) 1.74
Panic and phobic anxiety: defining phenotypes for genetic studies. Am J Psychiatry (1998) 1.66
On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol (1998) 1.53
Behavioral symptoms in mild cognitive impairment. Neurology (2004) 1.36
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.35
The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry (2007) 1.34
Memory biases in the anxiety disorders: current status. Clin Psychol Rev (2002) 1.33
Measurement and prediction of functional capacity in Alzheimer's disease. Neurology (1990) 1.31
Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline. Int J Geriatr Psychiatry (2003) 1.30
Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study. Clin Neurol Neurosurg (2006) 1.18
Depression, anxiety, and neuropsychological performance in coronary artery bypass graft patients: a follow-up study. Psychosomatics (2008) 1.15
Positive effect of patient education for hip surgery: a randomized trial. Clin Orthop Relat Res (2003) 1.13
Assessing older adults with generalized anxiety: a replication and extension. Behav Res Ther (2001) 1.13
Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment. Data from a cross-sectional study. Acta Neurol Scand Suppl (2003) 1.05
Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. J Adv Nurs (2004) 0.89
Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol (2006) 0.87
Mild cognitive impairment: what's in a name? Gerontology (2006) 0.86
Self-report measures of anxiety: are they suitable for older adults? Aging Ment Health (2007) 0.86
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect (2004) 5.19
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med (2012) 4.22
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther (1994) 4.18
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Food combination and Alzheimer disease risk: a protective diet. Arch Neurol (2010) 3.99
Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc (2002) 3.83
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med (1993) 3.45
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect (2006) 3.42
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry (2002) 2.56
Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol (2004) 2.55
Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect (2006) 2.50
Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45
Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol (2011) 2.44
Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr (2006) 2.41
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol (2005) 2.33
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27
Cognitive reserve and lifestyle. J Clin Exp Neuropsychol (2003) 2.27
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia (2006) 2.17
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke (2002) 2.08
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06
Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep (2004) 2.03
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99
Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect (2005) 1.97
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol (2008) 1.92
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr (2007) 1.91
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Age-related changes in brain activation during a delayed item recognition task. Neurobiol Aging (2006) 1.87
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh. Environ Health Perspect (2009) 1.83
Arsenic and manganese exposure and children's intellectual function. Neurotoxicology (2011) 1.82
Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol (2008) 1.81
An event-related fMRI study of the neurobehavioral impact of sleep deprivation on performance of a delayed-match-to-sample task. Brain Res Cogn Brain Res (2004) 1.80
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry (1999) 1.77
Attitudes and practices among internists concerning genetic testing. J Genet Couns (2012) 1.75
Disparities in the recording of Parkinson's disease on death certificates. Mov Disord (2005) 1.75
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage (2008) 1.74
Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh. Am J Clin Nutr (2005) 1.74
An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol (2006) 1.73
Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol (1985) (2005) 1.73
Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A (2010) 1.73
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol (1990) 1.71
Folic acid supplementation lowers blood arsenic. Am J Clin Nutr (2007) 1.70
Lack of familial aggregation of Parkinson disease and Alzheimer disease. Arch Neurol (2004) 1.67
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56
Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry (1996) 1.56
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord (2007) 1.55
Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci (2013) 1.54
Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord (2004) 1.54
The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry (1996) 1.53
A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet (2012) 1.52